• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Emerging new evidence for the treatment of pulmonary sarcomatoid carcinoma.肺肉瘤样癌治疗的新出现证据
J Thorac Dis. 2023 Mar 31;15(3):953-955. doi: 10.21037/jtd-22-1775. Epub 2023 Feb 23.
2
The Correlation Between Histologic, Immunophenotypic, and Molecular Characteristics of Pulmonary Sarcomatoid Carcinoma Reveals That Sarcomatoid Change Is Potentially Derived From Epithelial Carcinoma Cells Undergoing Epithelial-Mesenchymal Transition.肺肉瘤样癌的组织学、免疫表型和分子特征之间的相关性表明，肉瘤样改变可能源自经历上皮-间质转化的上皮癌细胞。
Appl Immunohistochem Mol Morphol. 2023 Jan 1;31(1):17-25. doi: 10.1097/PAI.0000000000001060. Epub 2022 Sep 27.
3
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma.肺肉瘤样癌的临床特征及预后因素
J Thorac Dis. 2022 Oct;14(10):3773-3781. doi: 10.21037/jtd-22-393.
4
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.肉瘤样成分百分比作为伴肉瘤样去分化肾细胞癌生存预后指标的研究
Urol Oncol. 2015 Oct;33(10):427.e17-23. doi: 10.1016/j.urolonc.2015.04.011. Epub 2015 May 23.
5
Clinicopathological features and prognostic analysis of metastatic pulmonary sarcomatoid carcinoma: a SEER analysis.转移性肺肉瘤样癌的临床病理特征及预后分析：一项监测、流行病学和最终结果（SEER）分析
J Thorac Dis. 2021 Feb;13(2):893-905. doi: 10.21037/jtd-20-2826.
6
The treatment of advanced pulmonary sarcomatoid carcinoma.晚期肺肉瘤样癌的治疗。
Future Oncol. 2022 Feb;18(6):727-738. doi: 10.2217/fon-2021-1071. Epub 2021 Dec 9.
7
Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.肺肉瘤样癌：51 例临床病理研究和预后分析。
World J Surg Oncol. 2013 Oct 2;11:252. doi: 10.1186/1477-7819-11-252.
8
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor.伴有ALK重排的肺肉瘤样癌：发生率、临床病理特征及对ALK抑制剂的反应
Transl Oncol. 2017 Apr;10(2):115-120. doi: 10.1016/j.tranon.2016.11.009. Epub 2017 Jan 10.
9
The Prognostic Significance Of JMJD3 In Primary Sarcomatoid Carcinoma Of The Lung, A Rare Subtype Of Lung Cancer.JMJD3在原发性肺肉瘤样癌（一种罕见的肺癌亚型）中的预后意义
Onco Targets Ther. 2019 Nov 7;12:9385-9393. doi: 10.2147/OTT.S225596. eCollection 2019.
10
[Current Status of Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma].[肺肉瘤样癌的诊断与治疗现状]
Zhongguo Fei Ai Za Zhi. 2018 Dec 20;21(12):902-906. doi: 10.3779/j.issn.1009-3419.2018.12.07.

本文引用的文献

1
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma.肺肉瘤样癌的临床特征及预后因素
J Thorac Dis. 2022 Oct;14(10):3773-3781. doi: 10.21037/jtd-22-393.
2
Immunophenotyping of pulmonary sarcomatoid carcinoma.肺肉瘤样癌的免疫表型。
Front Immunol. 2022 Oct 20;13:976739. doi: 10.3389/fimmu.2022.976739. eCollection 2022.
3
MET alterations in advanced pulmonary sarcomatoid carcinoma.晚期肺肉瘤样癌中的MET改变
Front Oncol. 2022 Sep 23;12:1017026. doi: 10.3389/fonc.2022.1017026. eCollection 2022.
4
Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma.55例肺肉瘤样癌患者的特征及预后分析
Front Oncol. 2022 May 3;12:833486. doi: 10.3389/fonc.2022.833486. eCollection 2022.
5
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.阿替利珠单抗联合贝伐单抗、紫杉醇和卡铂对SMARCA4缺陷型胸段肉瘤患者有效。
Immunotherapy. 2021 Jul;13(10):799-806. doi: 10.2217/imt-2020-0311. Epub 2021 May 25.
6
Recurrent spindle cell carcinoma of the lung successfully treated by chemoimmunotherapy.经化学免疫疗法成功治疗的复发性肺梭形细胞癌。
Respirol Case Rep. 2021 May 7;9(6):e00757. doi: 10.1002/rcr2.757. eCollection 2021 Jun.
7
Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis.额外的化疗可提高接受手术的II-III期肺肉瘤样癌患者的生存率：一项倾向评分匹配分析。
Ann Transl Med. 2021 Jan;9(1):24. doi: 10.21037/atm-20-3226.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.免疫检查点抑制剂在肺肉瘤样癌中的疗效。
J Thorac Oncol. 2020 May;15(5):860-866. doi: 10.1016/j.jtho.2020.01.014. Epub 2020 Jan 25.
10
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.c-MET 过表达不能预测肺肉瘤样癌中 MET 扩增或外显子 14 突变。
J Thorac Oncol. 2018 Dec;13(12):1962-1967. doi: 10.1016/j.jtho.2018.08.008. Epub 2018 Aug 24.

Emerging new evidence for the treatment of pulmonary sarcomatoid carcinoma.

作者信息

Akaba Tomohiro, Arimura Ken, Tagaya Etsuko

机构信息

Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

J Thorac Dis. 2023 Mar 31;15(3):953-955. doi: 10.21037/jtd-22-1775. Epub 2023 Feb 23.

DOI:10.21037/jtd-22-1775
PMID:37065595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10089887/
Abstract
摘要